BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 27003139)

  • 1. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
    Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
    BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.
    Sakata A; Fushimi Y; Okada T; Arakawa Y; Kunieda T; Minamiguchi S; Kido A; Sakashita N; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 Sep; 46(3):732-739. PubMed ID: 28252822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
    Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
    Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of Meningiomas and Gliomas by Amide Proton Transfer Imaging: A Preliminary Study of Brain Tumour Infiltration.
    Zhang HW; Liu XL; Zhang HB; Li YQ; Wang YL; Feng YN; Deng K; Lei Y; Huang B; Lin F
    Front Oncol; 2022; 12():886968. PubMed ID: 35646626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of APT imaging in gliomas grading: A systematic review and meta-analysis.
    Sotirios B; Demetriou E; Topriceanu CC; Zakrzewska Z
    Eur J Radiol; 2020 Dec; 133():109353. PubMed ID: 33120241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigated diagnostic value of synthetic relaxometry, three-dimensional pseudo-continuous arterial spin labelling and diffusion-weighted imaging in the grading of glioma.
    Ge X; Wang M; Ma H; Zhu K; Wei X; Li M; Zhai X; Shen Y; Huang X; Hou M; Liu W; Wang M; Wang X
    Magn Reson Imaging; 2022 Feb; 86():20-27. PubMed ID: 34808303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging.
    Hashido T; Saito S; Ishida T
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):606-613. PubMed ID: 34270479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences.
    Qin JB; Liu Z; Zhang H; Shen C; Wang XC; Tan Y; Wang S; Wu XF; Tian J
    Med Sci Monit; 2017 May; 23():2168-2178. PubMed ID: 28478462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability.
    Han X; Suo S; Sun Y; Zu J; Qu J; Zhou Y; Chen Z; Xu J
    J Magn Reson Imaging; 2017 Mar; 45(3):722-730. PubMed ID: 27527072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI.
    Wang X; Chen XZ; Shi L; Dai JP
    Clin Radiol; 2019 Aug; 74(8):651.e7-651.e14. PubMed ID: 31014573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.
    Han H; Han C; Wu X; Zhong S; Zhuang X; Tan G; Wu H
    J Neurooncol; 2017 May; 133(1):147-154. PubMed ID: 28439776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67 labeling index and the grading of cerebral gliomas by using intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling magnetic resonance imaging.
    Wang C; Dong H
    Acta Radiol; 2020 Aug; 61(8):1057-1063. PubMed ID: 31830431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma.
    Yao R; Cheng A; Zhang Z; Jin B; Yu H
    J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):322-328. PubMed ID: 36957971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.
    Park JE; Lee JY; Kim HS; Oh JY; Jung SC; Kim SJ; Keupp J; Oh M; Kim JS
    Eur Radiol; 2018 Aug; 28(8):3285-3295. PubMed ID: 29488086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.